AACR 2021: MSK Experts Featured at the AACR Annual Meeting Week 1

Share
Print
Samuel F. Bakhoum, MD, PhD, Matthew J. Matasar, MD, Ross L. Levine, MD, Michel Sadelain, MD, PhD

Thousands of oncology experts from around the world will tune in April 10-15 for the American Association for Cancer Research’s (AACR) Annual Meeting: Week 1. The meeting is the first of two virtual meetings, with clinical trial plenary sessions, clinical trial poster sessions, several minisymposia, and more. The AACR Annual Meeting: Week 2 will be held May 17-21.

The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world.

MSK physicians and scientists are involved in notable research to be presented at the meeting and are available to comment on topics including clinical trials, immunotherapy, tumor biology, drug development, experimental and molecular therapeutics, molecular and cellular biology, genetics and more. Several MSK experts will be taking part in high profile presentations:

  • Samuel F. Bakhoum, MD, PhD will present about chromosomal instability and tumor evolution during the plenary on Saturday, April 10 from 10:05-10:27 am ET. 
  • Matthew J. Matasar, MD will present findings from the study “CHRONOS-3: Randomized Phase III study of copanlisib plus rituximab vs rituximab/placebo in relapsed indolent non-Hodgkin lymphoma (iNHL)” during the Phase III Clinical Trials session on Saturday, April 10 from 11:30-11:45 am ET.
  • Ross L. Levine, MD will discuss clonal hematopoiesis and evolution to hematologic malignancies during the plenary on Monday, April 12 from 11:44 am-12:06 pm ET. 
  • Michel Sadelain, MD, PhD will present about novel CAR design during the plenary on Wednesday, April 14 from 11:44 am-12:06 pm ET. 

In addition to the exciting work from MSK being presented, Luis Alberto Diaz Jr., MD, Head of the Division of Solid Tumor Oncology, has been elected to the AACR Board of Directors for the 2021–2024 term.

For more information and to set up interviews, contact spencea3@mskcc.org. Registration is required for all attendees: https://www.aacr.org/meeting/aacr-annual-meeting-2021/registration/. Follow the meeting live on Twitter using the hashtag #AACR21 and follow MSK on Twitter at @sloan_kettering.